The proxy dilemma: Informed consent in paediatric clinical research - a case study of Thailand

Insights

Navigating legal uncertainty in pediatric research is crucial for ethical and lawful informed consent. International frameworks can help ensure children access clinical trials when national laws are unclear.

Area of Science:

  • Medical Law
  • Bioethics
  • Pediatric Research

Background:

  • Informed consent is a cornerstone of ethical and legal research involving human subjects.
  • Paediatric research requires authorization from a legal representative due to children's presumed lack of competence.
  • Legal uncertainty in determining who can provide consent can hinder children's participation in clinical research.

Purpose of the Study:

  • To explore how international legal frameworks can address legal uncertainty in informed consent for paediatric research.
  • To examine the implications of lacking or inadequate national laws on children's enrollment in clinical research.
  • To propose solutions for enabling greater child participation in paediatric clinical research, using Thailand as a case study.

Main Methods:

  • Analysis of international legal frameworks, specifically the UN Convention on the Rights of the Child.
  • Case study approach focusing on Thailand's legal and socio-cultural context regarding informed consent in paediatric research.
  • Examination of legal uncertainty and its impact on the informed consent process.

Main Results:

  • National laws may not always align with socio-cultural realities, creating legal ambiguity.
  • International conventions offer a potential basis for resolving legal uncertainties in informed consent.
  • Thailand's context highlights challenges in applying legal frameworks to paediatric research.

Conclusions:

  • Leveraging international legal frameworks can help navigate ambiguities in informed consent for paediatric clinical research.
  • Addressing legal uncertainty is vital for ensuring children can access and benefit from clinical research participation.
  • A harmonized approach considering both international law and local realities is needed to facilitate ethical paediatric research.

Related Concept Videos

Ethics in Research01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
24.7K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.7K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
8
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
10
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
11